Compare Enact Holdings Inc (ACT) vs DexCom, Inc. (DXCM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enact Holdings Inc vs DexCom, Inc. — how do they compare? Enact Holdings Inc trades at $49.07 (market cap $6.75B), while DexCom, Inc. trades at $89.2 (market cap $33.79B). The key difference: DexCom, Inc. is far larger — about 5× Enact Holdings Inc's market cap, and Enact Holdings Inc pays a 1.95% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| ACT | DXCM | |
|---|---|---|
Market Cap | $6.75B | $33.79B |
Sector | Technology | Health |
52-Week High | $49.12 | $89.53 |
52-Week Low | $34.93 | $54.84 |
Enterprise Value | $7.05B | $33.24B |
Dividend Yield | 1.95% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enact Holdings Inc
Enact Holdings is a leading private mortgage insurance provider in the U.S. It partners with lenders to offer credit enhancement and risk management solutions, helping more borrowers achieve and maintain homeownership.
Read more on ACT →About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →
